Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Pasithea Therapeutics Corp. | Chief Development Officer | Stock Option (right to buy) | 5.94K | Mar 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KTTA | Pasithea Therapeutics Corp. | Mar 1, 2024 | 1 | $0 | 4/A | Apr 5, 2024 | Chief Development Officer |
KTTA | Pasithea Therapeutics Corp. | Mar 1, 2024 | 1 | $0 | 4 | Mar 1, 2024 | Chief Development Officer |
KTTA | Pasithea Therapeutics Corp. | Jul 3, 2023 | 0 | $0 | 3 | Jul 3, 2023 | Chief Development Officer |